K062575

Substantially Equivalent

MODIFICATION TO: ACCUSIGN RC DOA 10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP

Applicant: Princeton BioMeditech Corp.
Product code: LAG
Advisory panel: Clinical Toxicology
Date received: 2006-08-31
Decision date: 2007-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.